Your browser doesn't support javascript.
loading
Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.
Douglass, Nicola; van Diepen, Michiel T; Chapman, Rosamund; Galant, Shireen; Margolin, Emmanuel; Ximba, Phindile; Hermanus, Tandile; Moore, Penny L; Williamson, Anna-Lise.
Afiliación
  • Douglass N; Division of Medical Virology, Department of Pathology, University of Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa. Electronic address: Niki.Douglass@uct.ac.za.
  • van Diepen MT; Division of Medical Virology, Department of Pathology, University of Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
  • Chapman R; Division of Medical Virology, Department of Pathology, University of Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
  • Galant S; Division of Medical Virology, Department of Pathology, University of Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
  • Margolin E; Division of Medical Virology, Department of Pathology, University of Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa; Wellcome Trust Centre for Infectious Disease Research in Africa, University of Cape Town, South Africa; Biophar
  • Ximba P; Division of Medical Virology, Department of Pathology, University of Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
  • Hermanus T; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Moore PL; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Centre for the AIDS Programme of Rese
  • Williamson AL; Division of Medical Virology, Department of Pathology, University of Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.
Vaccine ; 39(3): 463-468, 2021 01 15.
Article en En | MEDLINE | ID: mdl-33342638
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: VIH-1 / Vacunas contra el SIDA / Vacunas de ADN Límite: Animals País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: VIH-1 / Vacunas contra el SIDA / Vacunas de ADN Límite: Animals País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos